LEPU BIO-B (02157) Sets 25 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal

Bulletin Express

03/11

LEPU BIOPHARMA CO., LTD. (LEPU BIO-B, 02157) has scheduled a board meeting for 25 March 2026. Directors will examine and approve the consolidated financial statements for the year ended 31 December 2025, consider the declaration of a final dividend, and handle other routine matters.

The meeting will be chaired by Dr. Pu Zhongjie, who serves as both Chairman and Executive Director. The current board consists of two executive directors (Dr. Pu Zhongjie and CEO Dr. Sui Ziye), two non-executive directors (Ms. Pu Jue and Ms. Qin Yiran), and three independent non-executive directors (Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua).

The announcement was released from Shanghai on 11 March 2026. No further financial metrics or dividend figures were disclosed ahead of the scheduled meeting.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1161759806"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1161759806\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1161759806?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-11 21:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161759806","market":"hk","top_or_hot":-1,"title":"LEPU BIO-B (02157) Sets 25 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal","media":"Bulletin Express","content":"<p>LEPU BIOPHARMA CO., LTD. (LEPU BIO-B, 02157) has scheduled a board meeting for 25 March 2026. Directors will examine and approve the consolidated financial statements for the year ended 31 December 2025, consider the declaration of a final dividend, and handle other routine matters.</p>\n<p>The meeting will be chaired by Dr. Pu Zhongjie, who serves as both Chairman and Executive Director. The current board consists of two executive directors (Dr. Pu Zhongjie and CEO Dr. Sui Ziye), two non-executive directors (Ms. Pu Jue and Ms. Qin Yiran), and three independent non-executive directors (Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua).</p>\n<p>The announcement was released from Shanghai on 11 March 2026. No further financial metrics or dividend figures were disclosed ahead of the scheduled meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LEPU BIO-B (02157) Sets 25 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLEPU BIO-B (02157) Sets 25 March 2026 Board Meeting to Review FY 2025 Results and Final-Dividend Proposal\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-11 21:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>LEPU BIOPHARMA CO., LTD. (LEPU BIO-B, 02157) has scheduled a board meeting for 25 March 2026. Directors will examine and approve the consolidated financial statements for the year ended 31 December 2025, consider the declaration of a final dividend, and handle other routine matters.</p>\n<p>The meeting will be chaired by Dr. Pu Zhongjie, who serves as both Chairman and Executive Director. The current board consists of two executive directors (Dr. Pu Zhongjie and CEO Dr. Sui Ziye), two non-executive directors (Ms. Pu Jue and Ms. Qin Yiran), and three independent non-executive directors (Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua).</p>\n<p>The announcement was released from Shanghai on 11 March 2026. No further financial metrics or dividend figures were disclosed ahead of the scheduled meeting.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02157","symbol_name":"樂普生物-B","start_time":0,"source_url":"","article_id":"1161759806","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161759806","pubTimestamp":1773234193,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"LEPU BIOPHARMA CO., LTD. (LEPU BIO-B, 02157) has scheduled a board meeting for 25 March 2026. Directors will examine and approve the consolidated financial statements for the year ended 31 December...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02157":"乐普生物-B"},"translate_title":"乐普生物-B(02157)定于2026年3月25日召开董事会会议，审阅2025财年业绩及末期股息建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02157":1},"content_text":"LEPU BIOPHARMA CO., LTD. (LEPU BIO-B, 02157) has scheduled a board meeting for 25 March 2026. Directors will examine and approve the consolidated financial statements for the year ended 31 December 2025, consider the declaration of a final dividend, and handle other routine matters.\nThe meeting will be chaired by Dr. Pu Zhongjie, who serves as both Chairman and Executive Director. The current board consists of two executive directors (Dr. Pu Zhongjie and CEO Dr. Sui Ziye), two non-executive directors (Ms. Pu Jue and Ms. Qin Yiran), and three independent non-executive directors (Mr. Zhou Demin, Mr. Yang Haifeng and Mr. Fengmao Hua).\nThe announcement was released from Shanghai on 11 March 2026. No further financial metrics or dividend figures were disclosed ahead of the scheduled meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}